SEC Form 4 · accession 0001179110-15-006186

Assertio Therapeutics, Inc · ASRT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Senior VP, BD

Period of report

Apr 8, 2015

Accepted (ET)

Apr 9, 2015 · 4:50 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001005201

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Apr 8, 2015	M	52,500	$6.29	A	140,943	D
Common Stock	Apr 8, 2015	M	1,875	$3.60	A	142,818	D
Common Stock	Apr 8, 2015	M	335	$3.09	A	143,153	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option^F1	$6.29	Apr 8, 2015	M	52,500	D	—	Feb 10, 2016	Common Stock	52,500	D
Stock Option^F1	$3.60	Apr 8, 2015	M	1,875	D	—	Jan 25, 2018	Common Stock	1,875	D
Stock Option^F1	$3.09	Apr 8, 2015	M	335	D	—	Jan 7, 2020	Common Stock	335	D